R01DA051509
Project Grant
Overview
Grant Description
Large Data Spatiotemporal Modeling of Optimal Combinations of Interventions to Reduce Opioid Harm in the United States
The goal of this project is to prevent and reduce deaths and injuries due to opioids in the United States by determining the best combination of state and local harm reduction and drug paraphernalia laws needed to reduce overdose rates and other opioid-related harms. To do this, we will:
1) Conduct an original review of laws on relevant harm reduction and drug paraphernalia laws in the 836 municipalities with more than 50,000 people and associated counties.
2) Conduct biannual surveys on the implementation of harm reduction laws and drug paraphernalia laws by law enforcement.
3) Create an extensive national dataset by merging data on state and local harm reduction and drug paraphernalia laws, implementation of laws by law enforcement, EMS and fatality data, and information on local harm reduction resources and socioeconomic indicators.
4) Use the merged dataset to determine which combinations of state and local laws have resulted in the biggest decreases in overdoses and related harms.
5) Determine which local characteristics enhanced those effective combinations of policies.
Overdose deaths in the United States increased more than six-fold since 2001 and now account for more loss of life than high blood pressure, AIDS, and pneumonia. States, cities, and counties are combating this epidemic by passing laws to reduce overdoses and by investing in access to harm reduction services. However, these efforts are often undertaken in isolation and without considering how the different state and local laws interact or how local factors like enforcement of laws and access to harm reduction services influence their effectiveness.
This project will help answer those questions by using large data and powerful analytics to bring together all the evidence on this complicated topic. At the end of the project, we will be able to answer the following questions: What combinations of state and local harm reduction and drug paraphernalia laws most effectively prevent and reduce opioid deaths and injuries in the United States? And how can we best support local efforts to ensure that those effective combinations have the greatest impact?
The goal of this project is to prevent and reduce deaths and injuries due to opioids in the United States by determining the best combination of state and local harm reduction and drug paraphernalia laws needed to reduce overdose rates and other opioid-related harms. To do this, we will:
1) Conduct an original review of laws on relevant harm reduction and drug paraphernalia laws in the 836 municipalities with more than 50,000 people and associated counties.
2) Conduct biannual surveys on the implementation of harm reduction laws and drug paraphernalia laws by law enforcement.
3) Create an extensive national dataset by merging data on state and local harm reduction and drug paraphernalia laws, implementation of laws by law enforcement, EMS and fatality data, and information on local harm reduction resources and socioeconomic indicators.
4) Use the merged dataset to determine which combinations of state and local laws have resulted in the biggest decreases in overdoses and related harms.
5) Determine which local characteristics enhanced those effective combinations of policies.
Overdose deaths in the United States increased more than six-fold since 2001 and now account for more loss of life than high blood pressure, AIDS, and pneumonia. States, cities, and counties are combating this epidemic by passing laws to reduce overdoses and by investing in access to harm reduction services. However, these efforts are often undertaken in isolation and without considering how the different state and local laws interact or how local factors like enforcement of laws and access to harm reduction services influence their effectiveness.
This project will help answer those questions by using large data and powerful analytics to bring together all the evidence on this complicated topic. At the end of the project, we will be able to answer the following questions: What combinations of state and local harm reduction and drug paraphernalia laws most effectively prevent and reduce opioid deaths and injuries in the United States? And how can we best support local efforts to ensure that those effective combinations have the greatest impact?
Awardee
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
New York,
New York
100165267
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 351% from $709,418 to $3,201,014.
New York University was awarded
Optimal Opioid Harm Reduction Strategies in the US
Project Grant R01DA051509
worth $3,201,014
from National Institute on Drug Abuse in September 2022 with work to be completed primarily in New York New York United States.
The grant
has a duration of 4 years 9 months and
was awarded through assistance program 93.279 Drug Abuse and Addiction Research Programs.
The Project Grant was awarded through grant opportunity NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed).
Status
(Ongoing)
Last Modified 6/22/26
Period of Performance
9/30/22
Start Date
6/30/27
End Date
Funding Split
$3.2M
Federal Obligation
$0.0
Non-Federal Obligation
$3.2M
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for R01DA051509
Transaction History
Modifications to R01DA051509
Additional Detail
Award ID FAIN
R01DA051509
SAI Number
R01DA051509-2215694766
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Private Institution Of Higher Education
Awarding Office
75N600 NIH National Insitute on Drug Abuse
Funding Office
75N600 NIH National Insitute on Drug Abuse
Awardee UEI
M5SZJ6VHUHN8
Awardee CAGE
3D476
Performance District
NY-12
Senators
Kirsten Gillibrand
Charles Schumer
Charles Schumer
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| National Institute on Drug Abuse, National Institutes of Health, Health and Human Services (075-0893) | Health research and training | Grants, subsidies, and contributions (41.0) | $1,338,458 | 100% |
Modified: 6/22/26